# Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease

> **NCT01007578** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 14 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Stenotic Femoro-popliteal Arteries
- Occluded Femoro-popliteal Arteries
- Atherosclerosis

## Interventions

- **DEVICE:** Paclitaxel-coated balloon catheter angioplasty

## Key facts

- **NCT ID:** NCT01007578
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09-15
- **Primary completion:** 2007-12-15
- **Final completion:** 2007-12-15
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01007578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01007578, "Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01007578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*